Dihexa Based on 6 publication(s) in Google Scholar Dihexa, an oligopeptide drug, is an orally active and blood-brain barrier-permeable angiotensin IV analog
Both NAC and glutathione (liposomal or sublingual) have been shown to increase glutathione levels
Linagliptin, a DPP-4 inhibitor, ameliorates abeta (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of alzheimers disease
As a result, semaglutide continues to be recognized as the leading GLP-1 option for patients seeking evidence-based, medically supervised weight management in 2026
Prostaglandin I synthase (PGIS) catalyzes the isomerization of PGH2 to PGI2
No clinical trials directly compare metformin vs Ozempic for weight loss, but data from separate studies lets us see which causes more weight loss